The protective effect of astaxanthin on cisplatin-induced ototoxicity.

BACKGROUND Promising studies have been conducted with many substances to reduce the ototoxic effects of cisplatin, but there is no treatment that completely eliminates the ototoxic effect. OBJECTIVES To determine the effectiveness of astaxanthin (ASX) as a protective agent against cisplatin-induced ototoxicity. MATERIAL AND METHODS Thirty-six rats were randomly divided into 6 groups. Group 1 received no drug injections except for anesthetics; group 2 received intraperitoneal (IP) olive oil only for 8 days; group 3 received only IP ASX 75 mg/kg dissolved in olive oil for 8 days; group 4 received a single dose of only IP 16 mg/kg cisplatin on the 5th day; group 5 received 25 mg/kg ASX IP daily for 8 days and a single 16 mg/kg dose of cisplatin on the 5th day; group 6 received 75 mg/kg ASX IP daily for 8 days and a single 16 mg/kg dose of cisplatin on the 5th day. The animals were tested for distortion product otoacoustic emissions (DPOAE) before and 3 days after cisplatin treatment. The animals in all groups were sacrificed under anesthesia on the 10th day. Before sacrifice, inferior vena cava blood samples were drawn into commercial tubes for biochemical analysis and their cochlea were prepared for histological analysis. RESULTS The ASX+cisplatin groups demonstrated significantly higher DPOAE thresholds when compared to the cisplatin-only group (p < 0.05). The ASX 25 mg/kg/day+cisplatin group showed a significant increase in total antioxidant capacity compared to the cisplatin-only group, whereas the ASX 75 mg/kg/day+cisplatin group had significantly lower total oxidative stress and oxidative stress index. Histologic results showed that the cortical organ was better preserved in the ASX+cisplatin groups compared to the cisplatin-only group, and the degeneration in the spiral ganglion and inner and outer hair cells was less visible in the ASX groups. CONCLUSIONS Astaxanthin can protect hearing from cisplatin-induced ototoxicity, prevent cellular degeneration and significantly reduce oxidative stress.

[1]  E. Dursun,et al.  The protective effects of whortleberry extract against cisplatin-induced ototoxicity in rats , 2017, Brazilian journal of otorhinolaryngology.

[2]  Prof. Mohammed Abdalla Hussein,et al.  Astaxanthin; a Promising Protector Against Gentamicin-Induced Nephrotoxicity in Rats. , 2016, Current pharmaceutical biotechnology.

[3]  Chang-Hao Yang,et al.  Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats , 2016, PloS one.

[4]  Haijian Wu,et al.  Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases , 2015, Marine drugs.

[5]  Yi Li,et al.  The protective effect of astaxanthin on fetal alcohol spectrum disorder in mice , 2014, Neuropharmacology.

[6]  J. Ito,et al.  Effect of astaxanthin on vocal fold wound healing , 2014, The Laryngoscope.

[7]  M. Yousef,et al.  Beneficial effect of astaxanthin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced liver injury in rats , 2013, Toxicology and industrial health.

[8]  S. Karaçavuş,et al.  The effects of lycopene on cisplatin-induced ototoxicity , 2013, European Archives of Oto-Rhino-Laryngology.

[9]  Z. Yazıcı,et al.  Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract , 2011, European Archives of Oto-Rhino-Laryngology.

[10]  Alexander M. Wolf,et al.  Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. , 2010, The Journal of nutritional biochemistry.

[11]  L. Rybak Mechanisms of cisplatin ototoxicity and progress in otoprotection , 2007, Current opinion in otolaryngology & head and neck surgery.

[12]  M. Dolan,et al.  Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.

[13]  A. Martini,et al.  Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model. , 2006, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[14]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.

[15]  G. Song,et al.  Protective effect of astaxanthin on naproxen-induced gastric antral ulceration in rats. , 2005, European journal of pharmacology.

[16]  A. Kizilay,et al.  The protective effect of erdosteine against ototoxicity induced by cisplatin in rats , 2005, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[17]  O. Erel,et al.  A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.

[18]  G. Smoorenburg,et al.  Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery , 2003, Hearing Research.

[19]  Gene A Spiller,et al.  Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial. , 2003, Journal of medicinal food.

[20]  Y. Naguib Antioxidant activities of astaxanthin and related carotenoids. , 2000, Journal of agricultural and food chemistry.

[21]  T. Wong,et al.  A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. , 1999, Anticancer research.

[22]  W. J. Clerici,et al.  Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro , 1995, Hearing Research.

[23]  D. Bagger-sjöbäck,et al.  Dose-dependent inner ear changes after i.v. administration of cisplatin. , 1991, The Journal of otolaryngology.